- Home
- FXNC vs BIOA Comparison
FXNC vs BIOA Comparison
Compare FXNC & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FXNC | BIOA |
|---|---|---|
| Founded | 1907 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.4M | 255.6M |
| IPO Year | 2012 | 2024 |
Fundamental Metrics
Financial Performance| Metric | FXNC | BIOA |
|---|---|---|
| Price | $30.81 | $5.86 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $33.00 | $32.56 |
| AVG Volume (30 Days) | 13.5K | ★ 881.7K |
| Earning Date | 10-23-2026 | 11-09-2026 |
| Dividend Yield | ★ 2.20% | N/A |
| EPS Growth | ★ 96.00 | 66.21 |
| EPS | ★ 1.17 | N/A |
| Revenue | $7,717,000.00 | ★ $8,995,000.00 |
| Revenue This Year | $7.52 | N/A |
| Revenue Next Year | $4.62 | $97.72 |
| P/E Ratio | $26.34 | ★ N/A |
| Revenue Growth | ★ 7.40 | N/A |
| 52 Week Low | $22.40 | $4.81 |
| 52 Week High | $33.24 | $25.96 |
Technical Indicators
Market Signals| Indicator | FXNC | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 51.78 | 42.38 |
| Support Level | $30.17 | $4.81 |
| Resistance Level | $30.57 | $8.53 |
| Average True Range (ATR) | 0.83 | 0.39 |
| MACD | 0.17 | 0.21 |
| Stochastic Oscillator | 45.39 | 67.82 |
Price Performance
Historical ComparisonAbout FXNC First National Corporation
First National Corp is a bank holding company of First Bank, which is a commercial bank. Its core offering includes loans, deposits, wealth management, and other products and services. The Company operates through two reportable operating segments: Community Banking and wealth management. The Community Banking segment involves making loans and generating deposits from individuals, businesses, and charitable organizations. Wealth Management Services offers corporate trustee services, trust and estate administration, IRA administration and custody services. The company has revenue from Community Banking segment.
About BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.